42 results
Page 2 of 3
8-K
EX-10.1
92q0p fkzqrch8ou126l
7 Dec 20
Entry into a Material Definitive Agreement
6:02am
8-K
EX-10.1
fqhh m768
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
EX-10.23
568 qwq1gs
16 Mar 20
Annual report
11:09am
10-K
EX-10.1
cv367gia320nsj85sf
16 Mar 20
Annual report
11:09am
10-K
EX-10.24
t5reyjf
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
p0c03gn2d4xb14xe
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
10-Q
EX-10.16
aj9zmi7h2e gdnrd
14 Aug 19
Quarterly report
12:00am
10-Q
EX-10.20
dy2e1k8
14 Aug 19
Quarterly report
12:00am
10-Q
EX-10.21
4odk1w826 1af1
14 Aug 19
Quarterly report
12:00am
8-K
EX-10.1
l9hvqzcndz5yl c1p
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
w226860e6injxobygup
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.2
wcv6syj7ji8xjkr5hd3i
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K
EX-10.1
jac7k54c
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
8-K12B
EX-10.1
9gn3 zm4q
14 Jun 19
Notification of registration of securities
5:10pm
8-K12B
EX-10.2
9x8 qeazc
14 Jun 19
Notification of registration of securities
5:10pm